e-mailprint

Terumo Cardiovascular Systems continues to build production capacity and product portfolio

ANN ARBOR, Mich. — February 8, 2002 — Terumo Cardiovascular Systems Corporation confirmed that it has acquired some of the assets of Lifestream International, Incorporated, including: all assets associated with its cannulae and overpressure safety valve businesses; a newly built sterile products manufacturing facility in Matamoros, Mexico; and rights to distribute the Hemocor hemoconcentrator product line, manufactured by Minntech Corporation, in the U.S., Europe, Latin America, and most of Asia. Terumo Cardiovascular Systems develops, manufactures, and sells products to the global cardiac surgery market, with current emphasis in monitoring and cardiopulmonary bypass technologies.

The transaction provides Terumo Cardiovascular Systems with a fifth North American manufacturing facility and an increased share of the global cardiac surgery products market. The company, headquartered in Ann Arbor, Michigan, also operates manufacturing facilities in Ann Arbor, as well as Elkton, Maryland; Ashland, Massachusetts; and Tustin, California.

"This acquisition illustrates Terumo's commitment to the cardiac surgery market and is in line with our strategy to offer our customer base the best and broadest line of products for perfusion-related procedures," says Mark Sutter, President and CEO of Terumo Cardiovascular Systems. "We continue to build business in the market segments we currently serve while developing a foundation to serve new segments in the cardiac surgery market."

Terumo Cardiovascular Systems is a subsidiary of Terumo Medical Corporation, the U.S. subsidiary of Terumo Corporation of Japan. Terumo Corporation is a premier global medical company with 2001 annual sales of approximately $1.7 billion. Terumo Corporation manufactures, markets and sells a wide range of medical products including syringes, needles, catheters, and blood bags.